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Objectives: This study evaluates the feasibility of video-assisted minimally
invasive mitral valve surgery by means of the Port-Access system. The aim
of the study was to minimize surgical access and to develop a video-assisted
surgical technique. Methods: The Port-Access system allows for closed chest
endoluminal aortic clamping, cardioplegic arrest, and decompression of the
heart. The mitral valve was either repaired (n 5 28) or replaced (n 5 23)
in 51 patients by means of a minimally invasive approach through a right
lateral minithoracotomy and under videoscopic guidance. Results: Mean
length of incision was 5.4 6 1.8 cm (range 3.8 to 8 cm). Mean duration of
operation, cardiopulmonary bypass, and crossclamp time was 196 6 53,
133 6 52, and 72 6 27 minutes, respectively. Median intubation time was
25.5 hours (range 5 to 264 hours). Median duration of intensive care and
hospital stay was 2 days (range 1 to 36 days) and 13 days (10 to 36 days),
respectively. Hospital mortality was 9.8% (5/51). Overall morbidity was
relatively high. In two patients acute retrograde aortic dissection led to
conversion of the procedure. At follow-up (261 6 13 days), three patients
required reoperation for paravalvular leakage. Baseline mean Duke activity
index score was 19.3 6 11.3 before the operation and increased to 23.2 6 10
at 6 weeks’ and 24.2 6 10.3 at 12 weeks’ follow-up, respectively. Conclusion:
The Port-Access system allows for video-assisted minimally invasive re-
placement and complex repair of the mitral valve through a right lateral
minithoracotomy. However, morbidity and mortality associated with this
novel technique were high. (J Thorac Cardiovasc Surg 1998;115:567-76)
The Port-Access endovascular cardiopulmonarybypass system (EndoCPB, Heartport, Inc., Red-
wood City, Calif.) is a closed chest endovascular
system that enables aortic clamping, cardioplegic
arrest, cardiac decompression, and venting of the
left side of the heart.1-3 In animal models and
cadaver studies this technique has been used suc-
cessfully for minimally invasive coronary artery by-
pass grafting and mitral valve replacement.3, 4 First
clinical results have been recently reported.5, 6 This
report describes our early results with minimally
invasive mitral valve surgery performed with the
Port-Access system in 51 patients.
Methods
After approval by the local ethical committee of the
University of Leipzig, 51 consecutive patients (17 men, 34
women, mean age 61.8 6 10.7 years) with nonischemic
mitral valve disease were prospectively included in the
study from June 1996 to March 1997. All patients gave
written informed consent after the study protocol and the
potential risks associated with the procedure had been
outlined in detail. Demographics and preoperative patient
data are summarized in Table I.
Anesthesia. Patients were positioned in a supine posi-
tion with the right side of the chest slightly elevated.
Intravenous anesthesia with sufentanil, propofol, and pan-
curonium was administered. The airway was intubated
with a left-sided double-lumen endobronchial tube
(Mallinckrodt, Athlone, Ireland) in the first 10 patients,
whereas later in the series single-lumen intubation was
performed. An arterial pressure line was placed in the
right radial artery. A 5F single-lumen flow-directed pul-
monary artery catheter (Arrow International, Inc., Read-
ing, Pa.) was inserted through a 9F venous sheath in the
right jugular vein and positioned in the pulmonary artery
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under pressure control. A single-lumen 8.3F endovascular
pulmonary vent (Heartport) was then introduced and
positioned over the flow-directed catheter in the main
pulmonary artery. The vent was connected via an air relief
valve to the cardiopulmonary bypass venting line.
Surgery. All patients were operated on at the Heart-
center of the University of Leipzig by one experienced
surgeon. The right femoral artery and vein were surgically
exposed through a 3 to 4 cm incision parallel to the
inguinal skin fold. After systemic heparinization, a stan-
dard 28F venous return cannula (DLP, Inc., Grand Rap-
ids, Mich.) was placed in the femoral vein and advanced to
the right atrium under transesophageal echocardiographic
(TEE) control. A 21F or 23F Y-shaped arterial return
cannula (Heartport) with one arm for arterial return and
one arm for placement of the endovascular aortic clamp
was placed in the femoral artery. A conventional cardio-
pulmonary bypass system with roller pumps and mem-
brane oxygenator was used. In addition, a centrifugal
pump (Medtronic Bio-Medicus, Eden Prairie, Minn.) was
placed in the venous line to enhance venous drainage.
Synchronous with exposure of the femoral vessels, a
small horizontal incision was made laterally over the
fourth intercostal space between the anterior and median
axillary lines (Fig. 1). A specially designed rib retractor
(Arnold Medizintechnik, Tuttlingen, Germany) was in-
serted (Fig. 2). After initiation of cardiopulmonary bypass
the lungs were deflated. The pericardium was opened 3
cm above and parallel to the right phrenic nerve to expose
the roof of the left atrium. Exposure was enhanced by
placing three stay sutures in the pericardium, which were
transcutaneously fixed outside the chest. A 10 mm port
was inserted at the second intercostal space in the anterior
axillary line to allow placement of a videoscope (Endolive
3D Video Thoracoscope System, Carl Zeiss, Oberko-
chem, Germany) into the left atrium. Cardiopulmonary
bypass was instituted with the use of moderate hypother-
mia at 30° C. Before insertion of the endovascular aortic
clamp with the aid of TEE, the aorta was screened for
atheromatous debris and thrombi to avoid cerebral em-
bolization with retrograde perfusion. Advancement of the
guide wire could be visualized from the descending aorta
to the aortic valve by TEE. Correct placement of the
clamp (1 cm above the level of the sinotubular junction)
was controlled by fluoroscopy (Sieremobil 2000, Siemens,
Erlangen, Germany) and multiplane TEE (Vingmed 800
Fig. 1. Incision for minimally invasive Port-Access mitral
valve surgery.
Fig. 2. Specially designed rib retractor with integrated
arm to enhance exposure of the mitral valve and housing
a left atrial vent.
Table I. Patient characteristics and parameters of
cardiac function
Patient characteristics
Mean age (yr) 68.1 6 10.7
Male/female (n) 17/34
Reduced vital capacity (n) 8 (16%)
Hypertension (n) 20 (39%)
Diabetes (n) 13 (25%)
Preoperative NYHA functional class
Class I (n) 2
Class II (n) 11
Class III (n) 38
ASA class
Class II (n) 14
Class III (n) 32
Class IV (n) 5
Mitral valve and LV function
Mitral insufficiency . secondary (n) 39
Mitral stenosis . secondary (n) 12
Mitral valve orifice area (cm2) 2.8 6 1.5
DPmax (mm Hg) 7.8 6 6.8
DPmean (mm Hg) 3.2 6 3.8
Left ventricular end-diastolic diameter (mm) 50 6 13
Diameter of left atrium (mm) 52 6 11
Left ventricular end-diastolic pressure (mm Hg) 14 6 5
Ejection fraction (%) 57 6 13
Fraction of shortening (%) 27 6 10
Preoperative rhythm
Sinus rhythm (n) 18
Atrial fibrillation (n) 33
Tricuspid regurgitation (mild to moderate) (n) 32
NYHA, New York Heart Association; ASA, American Society of Anesthe-
siology; LV, left ventricular; DPmax, maximum pressure change; DPmean,
mean pressure change.
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CFM, Sonotron, Norway) (Fig. 3) in the first 20 patients.
Later in the series, placement of the clamp was guided by
TEE only.6 The endovascular aortic clamp was inflated to
endoluminally block the ascending aorta while the heart
was vented through the endovascular pulmonary vent and
the distal lumen of the endovascular aortic clamp in the
aortic root. After clamping, balloon pressure was contin-
uously measured and maintained between 250 and 340
mm Hg. Additional volume was inflated in case of a
decrease in balloon pressure below 220 mm Hg. Cold
crystalloid cardioplegic solution (Bretschneider HTK so-
lution, Ko¨hler Chemie, Alsbad, Germany) (2600 6 950
ml) was delivered antegradely through the distal endovas-
cular aortic clamp lumen while maintaining aortic root
pressure between 50 and 70 mm Hg. After cardiac arrest
had been established, the left atrium was opened and the
mitral valve exposed by a specially designed atrial retrac-
tor (Heartport) that was inserted through a second 5 mm
port at the sixth or seventh right intercostal space
parasternally. Mitral valve repair or replacement was
performed under three-dimensional videoscopic guidance
with the use of specially designed instruments (Heart-
port). After completion of the procedure the left atrium
was closed by a continuous suture. Deairing was per-
formed by inflation of the lungs and simultaneous reduc-
tion of venous drainage with the patient placed in the
Trendelenburg position. Deairing of the aortic root was
performed by suction via the distal lumen of the endovas-
cular aortic clamp. The endovascular aortic clamp was
deflated and the catheter was left in place for further
venting until deairing was completed. If necessary, defi-
brillation was performed via external defibrillation pads.
A temporary pacing wire (Biotronik, Berlin, Germany)
was placed in the pericardial sac. The endovascular aortic
clamp was then withdrawn and the chest wound closed. A
drainage tube was placed through the access port for the
stereoscope. After appropriate reperfusion, the arterial
and venous cannulas were removed and the femoral
vessels reconstructed.
Follow-up. Pain assessment during hospital stay and
follow-up was performed with the use of a visual analog
scale (0 to 10 cm) ranging from no pain (0) to most intense
pain (10). The patients were asked to mark the scale
corresponding to their pain perception. Preoperative and
postoperative activity level was judged by the Duke activ-
ity status index, a 12-item questionnaire that assesses
physical functioning.7 Follow-up examinations at 6 and 12
weeks included a physical examination, chest radiograph,
electrocardiogram, transthoracic echocardiogram, and
spirometric examination. Data are presented as median
and range or mean 6 standard deviation. Adverse events
are reported according to the guidelines for reporting
morbidity and mortality after cardiac valvular operations.8
Results
Catheter placement. Positioning of the endovas-
cular pulmonary vent was possible in all patients.
Cannulation in the groin was performed without
complication in all but one patient, in whom the
venous cannula could not be advanced transfemor-
ally into the inferior vena cava. In this patient the
incision was enlarged and the right atrium was
cannulated directly. Placement and positioning of
the endovascular aortic clamp was uneventful in all
but one patient. The tip of the balloon of the
Fig. 3. Intraoperative fluoroscopy showing inflated endovascular aortic clamp positioned in the ascending
aorta (left). Dye is injected via the distal lumen into the aortic root, visualizing the coronary arteries and
competent aortic valve. Intraoperative TEE of the aortic root (long-axis view 130 degrees) showing the
position of the endovascular aortic clamp at a distance of 2.6 cm from the aortic anulus (right).
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endovascular aortic clamp was placed at a distance
of 2 to 4 cm from the aortic valve anulus (mean
2.8 6 0.6 cm) (Fig. 3). In all patients, injection of an
initial volume of 20 to 35 ml (mean inflation volume
of 24 6 6 ml) resulted in sufficient aortic occlusion
with a balloon pressure in the desired range of 235
to 360 mm Hg. Larger volumes were observed in
patients with a large aorta. In six patients, additional
volumes had to be added because the balloon pres-
sure decreased below 220 mm Hg during the proce-
dure. Migration of the balloon during initial place-
ment was observed in six patients but was easily
corrected by external manipulation of the catheter
under TEE control. In one patient the balloon
migrated into the left ventricle in the middle of the
procedure, causing severe transaortic regurgitation.
Repeat dye injection after retraction of the balloon
confirmed severe aortic insufficiency. In this patient,
the operation was continued with the heart fibrillat-
ing. At the end of the procedure, aortic valve
function had completely recovered as demonstrated
by TEE. Balloon rupture was observed in another
patient and was noticed by the onset of ventricular
fibrillation. The operation was again completed with
the use of hypothermic fibrillatory arrest.
Surgical technique. In all patients, the mitral
valve was accessible through the right lateral
minithoracotomy. The mean length of the incision
was 5.4 6 1.8 cm (range 3.8 to 8 cm) with the last 20
patients having incisions of 4.5 cm or less. In the first
eight patients a partial resection of the fifth rib was
performed. In the last 43 patients, rib resection
could be avoided by using our custom-made rib
retractor. In one patient, insertion of the left atrial
retractor through the sixth intercostal space resulted
in injury of the distal right internal thoracic artery,
which necessitated its ligation.
In 28 patients, the mitral valve was repaired under
direct and stereoscopic vision by a combination of
repair techniques including quadrangular resection,
commissurotomy, sliding plasty, chordal replace-
ment, and annuloplasty with partial (Cosgrove ring,
Baxter Health Care Corporation, Santa Ana, Calif.)
or complete (Se´guin ring, St. Jude Medical, Inc., St.
Paul, Minn., or Physio ring, Baxter) mitral valve
rings (Table II). As demonstrated by intraoperative
TEE, successful repair was achieved in all but three
patients. One patient had new moderate mitral
stenosis (mitral valve orifice area 1.6 cm2) after a
complex repair of a calcified valve including quad-
rangular resection of the posterior leaflet. Two
patients had residual grade II mitral insufficiency. In
these patients, the mitral valve was replaced in the
same session by means of the same access and
surgical technique. Twenty-three patients (20 initial
operations and three after failed repair) underwent
mitral valve replacement with preservation of the
posterior mitral valve leaflet. Additional preserva-
tion of part of the anterior leaflet with resuspension
of its chordae was performed in seven patients. We
preferably use the rotatable St. Jude Medical mitral
valve (Master Series) because of its relatively soft
cuff, which allows for safer knot tying. Mean dura-
tion of operation, cardiopulmonary bypass, and
crossclamp times were 196 6 53, 133 6 52, and 72 6
27 minutes, respectively. In 37 patients, a spontane-
ous rhythm was present after the endovascular
aortic clamp was deflated, whereas 14 patients re-
quired one or more external defibrillations of 200 to
360 joules without evidence of skin irritation. In six
patients conversion to an enlarged thoracotomy
incision (n 5 2), a ministernotomy (n 5 2), or
complete sternotomy (n 5 2) was necessary. Acute
retrograde aortic dissection occurred in two pa-
tients. In one patient, TEE revealed a rapidly pro-
gressing dissection to the level of the aortic valve
with the onset of retrograde extracorporeal perfu-
sion. Emergency median sternotomy and supracoro-
nary replacement of the ascending aorta with recon-
struction of the aortic arch was performed with a
circulatory arrest time of 22 minutes. The mitral
valve was replaced conventionally. After a pro-
longed recovery, the patient was finally transferred
to a neurologic rehabilitation center. In another
patient aortic dissection became evident during
weaning from cardiopulmonary bypass. The patient
was converted to a median sternotomy and had
replacement of the ascending aorta but finally died
of persistent low cardiac output.
Postoperative course and complications. Primary
median intubation time was 25.5 hours (range 5 to
264 hours), with seven patients requiring ventilation
Table II. Types of procedures for which the Port-
Access system was used
Type of procedure n
Quadrangular resection and ring implantation 11
Isolated ring implantation 11
Isolated commissurotomy 1
Plication plasty and chordal replacement 2
Commissurotomy and ring implantation 2
Commissurotomy and chordae replacement 1
Sliding plasty 2
Mitral valve replacement 23
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for more than 48 hours. Duration of intensive care
and hospital stay was 2 days (range 1 to 36 days) and
13 days (10 to 36 days), respectively. In most pa-
tients pain medication could be stopped on the
second postoperative day. However, when they were
compared with a group of 20 patients who had
conventional mitral valve surgery via a median ster-
notomy, no significant difference in pain perception
was apparent (Fig. 4). Median blood loss was 800 ml
(range 175 to 2130 ml) with three patients requiring
reexploration for bleeding without enlarging the
primary incision. One patient was bleeding from the
videoscope port site and two had bleeding from
intercostal arteries after partial rib resection. Intra-
operative and postoperative complications are sum-
marized in Table III.
Five patients (9.8%) died in the perioperative
period or at follow-up. One patient with long-term
oral cortisone therapy died on postoperative day 12
after he had been referred to a specialized center for
treatment of toxic epidermal necrolysis that devel-
oped as a result of a superficial skin infection. One
patient who had successful mitral valve repair had
acute onset of recurrent mitral insufficiency on the
third postoperative day because the mitral ring had
torn free. Mitral valve replacement was performed
subsequently but the patient died of irreversible low
cardiac output. One patient died of pneumonia on
the sixth postoperative day after uneventful recov-
ery. One patient died of pulmonary embolism on
postoperative day 24 despite adequate anticoagula-
tion.
At discharge after mitral valve repair, all patients
had normal mitral valve function with no or only
trivial regurgitation. All implanted valves were func-
tioning normally, as shown by postoperative echo-
cardiographic studies. At a mean follow-up of 261 6
13 days, all patients except two had at least returned
to their preoperative activity level. Baseline mean
Duke activity index score was 19.3 6 11.3 before the
operation and increased to 23.2 6 10 at 6 weeks’ and
24.2 6 10.3 at 12 weeks’ follow-up, respectively.
New York Heart Association class had improved at
least by one class in all but six patients. The patient
with phrenic nerve palsy was still limited by tachy-
pnea and had reduced vital capacity. In all other
patients, respiratory function had normalized.
Three patients who had mitral valve replacement
and normal mitral valve function at their pre-dis-
charge echocardiographic examination were read-
mitted with paravalvular leakage after 5, 7, and 16
weeks, respectively. One patient was transferred
shortly before her routine 6-week outpatient fol-
low-up examination with acute onset of dyspnea.
This patient underwent a successful reoperation
using a conventional approach via a median sternot-
omy. At the time of reoperation, one of the sutures
that had been placed through the heavily calcified
posterior segment of the mitral valve anulus was
found to have torn. In one asymptomatic patient,
Fig. 4. Day by day pain perception graded by visual analog scale (VAS). Comparison of 20 patients
undergoing conventional mitral valve surgery (conv.) as compared with 20 patients who underwent the
minimally invasive procedure (MIC). Error bars indicate standard error of the mean. d, Days.
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non-pledget-supported sutures had been used at the
primary operation. One patient with symptomatic
paravalvular leakage had ongoing endocarditis at
the time of the primary operation. At reoperation,
the knots appeared to be tight, but some sutures had
torn through the mitral valve anulus. Both patients
underwent successful reoperations performed
through a median sternotomy. Remarkably, in all
patients there were almost no adhesions at reopera-
tion. In all except three patients, wound healing at
the groin was uncomplicated. Two patients had a
small residual hematoma and one patient had a
lymph fistula in the right groin, all of which were
treated conservatively. However, at 12 weeks’ fol-
low-up, three patients had increased flow (.3
m/sec) at the femoral artery as demonstrated by
Doppler studies, indicating mild stenosis at the level
of cannulation.
Discussion
Minimally invasive procedures were introduced in
expectation of reducing postoperative pain, recovery
time, and cost while providing a favorable cosmetic
result as compared with conventional surgery. With
the use of the Port-Access system, mitral valve
surgery including complex repair procedures
through an incision less than 4 cm has become
possible. The three-dimensional view provided by
the stereoscope facilitates repair procedures be-
cause it provides a detailed visualization of all valve
structures.
With increasing experience, cardiopulmonary by-
pass and crossclamp times became shorter in this
series. The length of the thoracotomy incision has
steadily decreased, and partial rib resection is no
longer performed. However, serious complications
occurred. Two retrograde aortic dissections were of
major concern. Both events were most likely caused
by intimal dissection at the level of the iliac artery
induced by the guide wire. Retrograde flow led to
complete retrograde aortic dissection. Because of
the limited experience with the Port-Access system,
no conclusions can be drawn to determine the
relative risk for the described severe complication.
However, as of May 1997, the Heartport World
Wide Registry reported aortic dissection in 11 of 610
patients undergoing Port-Access surgery,9 a number
that clearly exceeds the incidence of aortic dissec-
tion after conventional cardiac operations.10 Al-
though only one death was clearly procedure re-
Table III. Perioperative complications
Complications Cause n
Cardiac
Prolonged catecholamine support (,3 days) 9
Rhythm disorders Supraventricular tachycardia 8
Intermittent AV-block 2
Bleeding







Reintubation for respiratory insufficiency Right phrenic nerve palsy 1
Atelectasis, pneumonia 3
Prolonged ventilation . 48 hr Atelectasis, pneumonia 4
Pneumothorax, skin emphysema 5
Pleural effusion 5
Neurologic
Postoperative confusion Embolism (?) 9
Hemiplegia (transient) Aortic dissection, balloon displacement (?), embolism (?) 4
Vascular/groin
Lymph fistula 1
Delayed wound healing 1
Other
Aortic dissection Perforation of aortic wall 2
Renal failure (CVVH) Low cardiac output 2
Pancreatitis Unknown 1
Upper GI bleed Stress ulceration 1
Toxic skin necrolysis Unknown 1
CVVH, Continuous veno-venous hemofiltration; GI, gastrointestinal.
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lated, the mortality associated with the procedure in
this single-center experience exceeded our own and
the reported mortality for conventional surgery for
nonischemic mitral valve insufficiency or mitral ste-
nosis.11 In addition, there was considerable morbid-
ity not allowing for a reduction of mean hospitaliza-
tion time. The duration of intubation could not be
reduced as compared with standard mitral valve
repair or replacement. This might be explained by
the use of single-lung ventilation in the beginning of
the series, resulting in residual atelectasis during
recovery. We therefore abandoned double-lumen
intubation and instead attempt to maintain a mini-
mum of ventilation to both lungs. With increasing
experience, bleeding problems became less frequent
as potential bleeding sites were identified and elim-
inated by careful videoscopic inspection of port sites
and by abandoning rib resection. A problem that
was infrequently encountered early in this series was
incomplete deairing of the heart, which might par-
tially explain the high incidence of postoperative
confusion. Enhancement of the venting capacity of
the endovascular aortic clamp might further reduce
this problem. Surgical manipulation of the valve and
the perivalvular tissue is limited by a decreased
range of movement and the use of longer instru-
ments with limited stability. Especially in the pres-
ence of annular calcification, placement of sutures
can be difficult. Knotting is performed outside the
chest and knots are placed with the use of a knot-
pusher. This is a time-consuming and relatively inse-
cure procedure, which prolongs aortic crossclamp time
by 10 to 15 minutes. Refinement of the currently used
instruments is therefore highly desirable.
Manipulation of an atherosclerotic aorta (i.e.,
aortic clamping, cannula insertion) may result in
atheroembolism causing neurologic damage.12-14
Although some investigators believe that internal
balloon occlusion of the aorta is a safe procedure,
which is advantageous in patients with a calcified
aorta,15 it is as yet not known if an internal clamping
pressure of up to 360 mm Hg applied for as long as
2 hours is of no harm. In one patient who required
conversion for bleeding, we noticed a subadventitial
hemorrhage of the ascending aorta. With TEE,
aortic dissection was excluded so that surgical inter-
vention was not required. The tendency of the
balloon to migrate requires continuous observation.
Proximal displacement may, in theory, damage the
aortic valve, and distal migration may obstruct the
brachiocephalic trunk. We observed transient hemi-
paresis in four patients, a possible cause being
temporary translocation of the balloon. There was
no change in right radial artery pressure, so that
monitoring of right radial artery pressure alone
cannot be considered reliable for exclusion of bal-
loon displacement. Once the left atrium is opened,
TEE also fails to locate the balloon properly. Clearly
a method to continuously monitor balloon position
and carotid artery flow should be introduced. In the
last 10 cases we applied transcranial Doppler mea-
surements to detect emboli and to continuously
monitor blood flow in the middle cerebral arteries.
With femoral cannulation and retrograde aortic
flow, there is the potential disadvantage of flushing
debris of atheromatous plaques originating from the
abdominal or thoracic aorta into the cerebral circu-
lation. It is therefore mandatory to examine the
aorta with TEE before placement of the endovascu-
lar aortic clamp to identify patients with atheroma-
tous aortic plaques or thrombi and to exclude these
patients from an approach that requires retrograde
perfusion. In addition, femoral cannulation may
cause local complications at the groin, as well as
ischemic complications of the leg.16 Careful patient
selection excluding patients with severe atheroscle-
rosis, kinking, or ectasia of the aorta and the periph-
eral arteries is therefore advisable.
The term “minimally invasive” has been applied
to a number of different techniques for mitral valve
procedures,17-19 but there is still no agreement on
what type of procedure should be called minimally
invasive.20 Navia and Cosgrove21 reported on 25
patients who had a 10 cm right parasternal incision
with resection of the third and fourth cartilages and
sacrifice of the right internal thoracic artery. Unfor-
tunately, these authors provided no data to support
the conclusion that the smaller incision resulted in a
reduction of patient discomfort, a reduction in the
incidence and risks of wound infection and blood
loss, and a reduction of recovery time and costs. For
these questions to be appropriately answered, con-
trolled randomized studies enrolling larger series of
patients may be necessary. In several patients (in-
cluding those having reoperations) we have per-
formed minimally invasive mitral valve repair with
the use of hypothermic fibrillatory arrest, as initially
suggested by Lin and associates.22 A different ap-
proach for less invasive mitral valve replacement via
a midaxillary thoracotomy, applying femoro-femoral
bypass and direct transcutaneous aortic clamping
with a modified aortic clamp inserted through an
additional posterior axillary line incision, has been
suggested by Chitwood and colleagues.23 Although
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the incision is not as small as with the Port-Access
procedure, this approach seems to provide safe
antegrade cardioplegic cardiac arrest. Both tech-
niques avoid the use of additional catheters that
clearly increase the overall costs of the procedure.
Our initial experience applying this technique in
eight patients is very satisfying.
In conclusion, the results of our preliminary study
with the video-assisted Port-Access technique have
to be judged with caution because a number of
serious complications developed. In the last 28
patients who have been operated on since this
manuscript was submitted, the morbidity was low
and no deaths occurred. Average ischemic time
could be further reduced to less than 50 minutes.
Clearly, the design and instrumentation of the Port-
Access system needs further improvement, includ-
ing an antegrade perfusion system to enhance the
safety and the efficacy of the approach. The current
technique should be restricted to well-trained sur-
geons with a high volume of cases, so that they can
gain sufficient experience with this novel procedure.
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Discussion
Dr. W. Randolph Chitwood, Jr. (Greenville, N.C.). Dr.
Mohr has presented among the first series of patients
undergoing video-assisted minimally invasive mitral valve
surgery. He and his colleagues are to be applauded for
their careful and critical evaluation of their results. He has
emphasized that these techniques are in evolution, with
potentially a steep learning curve. In this series a right
anterolateral minithoracotomy was used. Centrifugal
pump-assisted venous drainage was used in conjunction
with retrograde femoral arterial perfusion. Complex mi-
tral valve repairs were done in 29 patients with good
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results. Three-dimensional videoscopy was very helpful in
these patients. Postoperative pain indices were low and
activity scores high. However, intubation and intensive
care times were not reduced compared with other mitral
valve operations. Moreover, the operative mortality was
9.8%. For comparison, the Heartport method has pro-
vided a 6.3% mortality for the over 250 patients having
mitral operations worldwide to date.
In Dr. Mohr’s series, technique-related complications
were significant. In two instances the intraaortic balloon
clamp either migrated into the ventricle or ruptured. In
five patients a transient hemiparesis developed, presum-
ably as a result of proximal balloon displacement. There
were two cases of retrograde aortic dissection.
Recently our group at East Carolina University has
performed 31 video-assisted mitral valve operations using
a minithoracotomy and direct aortic occlusion with a new
percutaneous transthoracic aortic clamp. Our results at
present suggest lower cost, shorter hospital stays, and a
3.2% mortality. Moreover, we had no neurologic compli-
cations and no aortic injuries. We believe that the clamp
method may be more secure, safer, and more economical
than balloon occlusion.
I have three questions for Dr. Mohr. In this initial
series, how have you selected and screened your patients
before the operation? From what you have learned al-
ready, how can neurologic events be avoided? How do you
think direct aortic occlusion may compare in the long run
with these more expensive balloon occlusive devices?
We agree with Dr. Mohr that video assistance can
facilitate portions of these operations quite well. How-
ever, the development of intracardiac video-dexterity re-
quires a learning curve. Using standard two-dimensional
thoracoscopic vision, we have found chordal transfers and
quadrangular resections difficult without direct vision, but
they can be done.
Dr. Mohr, please give us your thoughts regarding the
Zeiss three-dimensional stereoscope used in your cases.
Also, if you can, compare this with the other commercial
three-dimensional visioning devices available.
This paper has provided important new information
regarding these evolving techniques. However, we must
remain circumspect regarding operative safety and valve
durability until long-term results are delivered that com-
pare with results of conventional operations.
Dr. Eugene Grossi (New York, N.Y.). At New York
University we have performed 100 minimally invasive
procedures in which the endovascular aortic clamp was
used and with a complication rate that is less than in your
report. This raises some concerns relating to your tech-
nique. First, did you meticulously adhere to Seldinger
guide-wire techniques? We have not seen dissection when
these principles were adhered to. In which patients did
you intraoperatively abandon the attempt to use retro-
grade perfusion? Finally, with regard to neurologic com-
plications, what are your deairing guidelines? These tech-
nical issues are very important as we learn this new
technology.
Dr. Alain F. Carpentier (Paris, France). I rise to con-
gratulate Dr. Mohr for bringing to our attention the
potential complications linked with any type of video-
assisted minimally invasive surgery. Starting as early as
February 1996, we have used different techniques of
video-assisted minimally invasive surgery, including the
Heartport system. We have 22 mitral valve reconstruc-
tions with no deaths and only one case of reoperation.
Using the Heartport system, we found that it is possible
to place a balloon with TEE without requiring fluoros-
copy. You mentioned TEE. Would you now avoid using
fluoroscopy? Second, on the basis of your experience,
what are your current indications and contraindications
for minimally invasive surgery and for the Heartport
system? Third, we have been somewhat disappointed by
the pain after this operation when using thoracotomy.
How do you manage this problem, since one of the
potential advantages of minimally invasive techniques is to
reduce disability and pain for the patient.
Dr. Mohr. We have used an independent investigator to
evaluate pain in all of our 250 patients who underwent
minimally invasive surgery. As yet, the results are very
disappointing. Among our German patients pain percep-
tion is very similar. Maybe it is different in the United
States. We could not demonstrate significant differences,
neither for our 115 patients who had coronary bypass
surgery nor for our 50 patients having aortic valve replace-
ment via small incisions.
Concerning the other remarks, during the time encom-
passed by this study, 250 patients underwent conventional
mitral valve surgery. In the 50 patients we followed a
protocol that was part of a multicenter study which
regulated the selection of patients. Patients who were
older than 75 years, having concomitant cardiac disease,
and having reoperations were not included in the study.
We selected the patients carefully. However, some of
them had pulmonary hypertension as a consequence of
severe long-lasting mitral valve disease. We also per-
formed 30 other approaches. We followed Professor
Carpentier’s, Professor Cosgrove’s, and also Professor
Chitwood’s techniques. We tried to exclude very obese
patients for the Heartport technique because the distance
from the incision sometimes exceeded the length of the
instruments.
I mentioned that we also used clamping techniques. I
have used Dr. Chitwood’s technique with direct aortic
clamping in eight patients so far. The only concern is that
if you operate through an incision as small as 4 cm, and
you place the clamp through a port, in my eyes it is still
difficult to safely place the clamp at the ascending aorta
and not injure the pulmonary artery. You can solve this
problem if you go for a larger incision, more anteriorly.
The reason we chose the lateral incision is for optimal
view of the valve, which is then directly in view.
We tried several two-dimensional and three-dimen-
sional videoscopic systems. However, if you use the very
small incisions, the three-dimensional system is extremely
helpful, especially in complex repairs. For example, it is
almost impossible to adjust the length of the chordae with
a polytetrafluoroethylene suture using a two-dimensional
videoscopic system; the three-dimensional system is also
advantageous to estimate the coaptation of the valves
after repair. I did not have the chance to work with the
Vista System (VISTA Cardiothoracic Surgery, Westbor-
ough, Mass.), which is available in the United States.
However, I am uneasy about having so much electronic
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equipment on my head. At least on the European market
the Zeiss three-dimensional system was, in our eyes, a
superior system.
Now I would like to answer Dr. Grossi’s question. Of
course we use guide wires. I think the guide wire supplied
with this system is very stiff and may create an intimal tear
at the site of the iliac arteries. We had the unfortunate
opportunity to do an autopsy on one of our patients who
died because of early dissection. The reason for the
retrograde dissection was an intimal tear at the site of the
common iliac artery.
If you look at the history of our two dissections, the
guide wire was advanced into the ascending aorta, and
so was the balloon, under guidance in the first case with
fluoroscopy and echo. Nothing happened at the time of
insertion, but rather when we started retrograde perfu-
sion. The retrograde dissection expanded from the
abdominal to the descending and ascending aorta. I
think the underlying mechanisms are intimal tears that
lead to dissections with retrograde perfusion. We have
to find a way to perfuse the descending aorta that might
solve the problem. I know Heartport is working on this
very intensively and I am looking forward to a new
device.
In my eyes, deairing is still a problem because every-
body is used to a needle vent in the ascending aorta at the
roof of the ascending aorta. This is not possible with the
current Port-Access approach. At the beginning, we did
see ST elevation in almost all patients when we released
the balloon clamp. We changed our protocol in the last 30
patients, and as soon as the valve is replaced or repaired,
we reperfuse the aortic root with blood, with the balloon
still inflated. We position the patient very much to the left
side, cannulate the left ventricle through the mitral valve,
and then close the left atrium while the heart is already
beating. Nevertheless, sometimes air is continuously re-
leased when the heart is already beating and the venting
capacity of the endovascular clamp is not effective.
We never use retrograde cardioplegia in our patients. If
we have a prolonged crossclamp time, we repeat ante-
grade cardioplegia through the endovascular clamp. I am
reluctant to use a retrograde percutaneous catheter be-
cause of the risk of injuring the coronary sinus. The sinus
cannot be reached through this small incision.
Professor Carpentier, we abandoned fluoroscopy. Our
residents, like Dr. Falk, are very experienced in guiding
the endovascular aortic clamp placement, the guide wire,
through the descending aorta, through the arch, to its final
position in the ascending aorta, and using fluoroscopy is a
nuisance.
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